Perospirone — CAS 150915-41-6

Perospirone is an atypical antipsychotic agent with combined dopamine D2 and serotonin 5-HT2A receptor antagonism, as well as partial agonism at 5-HT1A receptors. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. Approved in Japan under the brand name Lullan, Perospirone is used in the treatment of schizophrenia and has a favorable side effect profile with lower risk of extrapyramidal symptoms compared to typical antipsychotics.

• Schizophrenia treatment — approved atypical antipsychotic
• Bipolar disorder mania management (investigational/adjunct)
• Schizoaffective disorder symptom control
• Treatment-resistant psychotic conditions

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support